PaxMedica, Inc. (PXMD)
0.0005
0.00 (0.00%)
USD |
OTCM |
Sep 09, 16:00
PaxMedica Debt to Equity Ratio
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | -2.945 |
| June 30, 2023 | 0.735 |
| Date | Value |
|---|---|
| March 31, 2023 | 0.6084 |
| December 31, 2022 | 3.074 |
| September 30, 2022 | 0.0655 |
| June 30, 2022 | -0.1531 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Cocrystal Pharma, Inc. | 1.284 |
| CNBX Pharmaceuticals, Inc. | -0.4388 |
| GB Sciences, Inc. | -- |
| Yulong Eco-Materials Ltd. | -- |
| Arvinas, Inc. | 0.0146 |